Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of bendamustine + dexamethasone + thalidomide in relapsed or refractory multiple myeloma
2011-001775-39Phase 2Completed
- Sponsor
- Azienda Sanitaria dell'Alto Adige
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bendamustine in multiple myeloma (MM), sponsored by Azienda Sanitaria dell'Alto Adige. Primary endpoint: Response rate. Started Mar 2012; status: completed.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2011-001775-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001775-39.